Brief: AB Science: strategy to increase the value of masitinib and to consider NASDAQ listing

AB Science SA

28/06/2021 19:08

June 28 (Reuters) - AB Science SA  ABS.PA :
    * AB SCIENCE ANNOUNCED TODAY THAT IT HAS SIGNED AN AGREEMENT
WITH
HISTORICAL SHAREHOLDERS TO IMPLEMENT A JOINT STRATEGY TO
INCREASE VALUE OF MASITINIB
    * To study the opportunity of listing AB Science on a
foreign
market, in particular the NASDAQ
    * This agreement also includes the signature of a firm
financing
option for an amount of €25 million over the next 12 months, at
the initiative of AB Science

Source text for Eikon:  ID:nGNE6WF6jN 
Further company coverage:  ABS.PA 

 (Reporting by Sudip Kar-Gupta)
 ((sudip.kargupta@thomsonreuters.com;))